BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 37788619)

  • 1. Retention and Overdose Risk among Patients Receiving Substance Use Disorder Treatment, Mental Health Care and Peer Recovery Support: A Longitudinal Analysis.
    Park JN; Agee T; McCormick S; Felsher M; Collins K; Hsu J; Schweizer N; Lucas G; Falade-Nwulia O
    J Addict Med; 2023 Sep-Oct 01; 17(5):608-611. PubMed ID: 37788619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recovery schools for improving behavioral and academic outcomes among students in recovery from substance use disorders: a systematic review.
    Hennessy EA; Tanner-Smith EE; Finch AJ; Sathe N; Kugley S
    Campbell Syst Rev; 2018; 14(1):1-86. PubMed ID: 37131375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implementing a peer-supported, integrated strategy for substance use disorder care in an outpatient infectious disease clinic is associated with improved patient outcomes.
    Falade-Nwulia O; Agee T; Kelly SM; Park JN; Schwartz S; Hsu J; Schweizer N; Jones J; Keruly J; Shah N; Lesko CR; Lucas GM; Sulkowski M
    Int J Drug Policy; 2023 Nov; 121():104191. PubMed ID: 37740989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studying how state health services delivery policies can mitigate the effects of disasters on drug addiction treatment and overdose: Protocol for a mixed-methods study.
    Eisenberg MD; McCourt A; Stuart EA; Rutkow L; Tormohlen KN; Fingerhood MI; Quintero L; White SA; McGinty EE
    PLoS One; 2021; 16(12):e0261115. PubMed ID: 34914779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of substance use disorders and drug overdose with adverse COVID-19 outcomes in New York City: January-October 2020.
    Allen B; El Shahawy O; Rogers ES; Hochman S; Khan MR; Krawczyk N
    J Public Health (Oxf); 2021 Sep; 43(3):462-465. PubMed ID: 33367823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of a Peer-Led Behavioral Intervention for Emergency Department Patients at High Risk of Fatal Opioid Overdose: A Randomized Clinical Trial.
    Beaudoin FL; Jacka BP; Li Y; Samuels EA; Hallowell BD; Peachey AM; Newman RA; Daly MM; Langdon KJ; Marshall BDL
    JAMA Netw Open; 2022 Aug; 5(8):e2225582. PubMed ID: 35943744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of VA's video telehealth tablets on substance use disorder care during the COVID-19 pandemic.
    Gujral K; Van Campen J; Jacobs J; Kimerling R; Zulman DM; Blonigen D
    J Subst Use Addict Treat; 2023 Jul; 150():209067. PubMed ID: 37164153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peer support to reduce readmission in Medicaid-enrolled adults with substance use disorder.
    Hutchison SL; MacDonald-Wilson KL; Karpov I; Herschell AD; Carney T
    J Subst Abuse Treat; 2023 Jan; 144():108901. PubMed ID: 36302294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implementing hospital-based peer recovery support services for substance use disorder.
    Liebling EJ; Perez JJS; Litterer MM; Greene C
    Am J Drug Alcohol Abuse; 2021 Mar; 47(2):229-237. PubMed ID: 33216634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Receipt of Telehealth Services, Receipt and Retention of Medications for Opioid Use Disorder, and Medically Treated Overdose Among Medicare Beneficiaries Before and During the COVID-19 Pandemic.
    Jones CM; Shoff C; Hodges K; Blanco C; Losby JL; Ling SM; Compton WM
    JAMA Psychiatry; 2022 Oct; 79(10):981-992. PubMed ID: 36044198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No change in substance use disorders or overdose after implementation of state Earned Income Tax Credit (EITC).
    van Draanen J; Peng J; Ye T; Williams EC; Hill HD; Rowhani-Rahbar A
    Drug Alcohol Depend; 2024 Jul; 260():111344. PubMed ID: 38838479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of co-occurring mental illness and substance use disorder and association with overdose: a linked data cohort study among residents of British Columbia, Canada.
    Keen C; Kinner SA; Young JT; Jang K; Gan W; Samji H; Zhao B; Krausz M; Slaunwhite A
    Addiction; 2022 Jan; 117(1):129-140. PubMed ID: 34033179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Racial differences in COVID-19 severity associated with history of substance use disorders and overdose: Findings from multi-site electronic health records in New York City.
    Allen B; Basaraba C; Corbeil T; Rivera BD; Levin FR; Martinez DM; Schultebraucks K; Henry BF; Pincus HA; Arout C; Krawczyk N
    Prev Med; 2023 Jul; 172():107533. PubMed ID: 37146730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Impact of the COVID-19 Pandemic on Drug Use Behaviors, Fentanyl Exposure, and Harm Reduction Service Support among People Who Use Drugs in Rural Settings.
    Bolinski RS; Walters S; Salisbury-Afshar E; Ouellet LJ; Jenkins WD; Almirol E; Van Ham B; Fletcher S; Johnson C; Schneider JA; Ompad D; Pho MT
    Int J Environ Res Public Health; 2022 Feb; 19(4):. PubMed ID: 35206421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Individual and social network correlates of recent treatment for substance use disorders among persons who use drugs in Baltimore, MD (2014 - 2017).
    E Rudolph A; Fernau DJ; Tobin KE; Latkin C
    Drug Alcohol Depend; 2020 Dec; 217():108278. PubMed ID: 32949885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of an osteopathic peer recovery coaching model on treatment outcomes in high-risk men entering residential treatment for substance use disorders.
    Crowthers RA; Arya M; Venkataraman A; Lister JJ; Cooper SE; Enich M; Stevens S; Bender E; Sanders R; Stagliano K; Jermyn RT
    J Osteopath Med; 2022 Oct; 122(10):521-529. PubMed ID: 35802066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment Disruption and Childcare Responsibility as Risk Factors for Drug and Alcohol Use in Persons in Treatment for Substance Use Disorders During the COVID-19 Crisis.
    Huhn AS; Strain EC; Jardot J; Turner G; Bergeria CL; Nayak S; Dunn KE
    J Addict Med; 2022 Jan-Feb 01; 16(1):e8-e15. PubMed ID: 33560698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expanding access to substance use services and mental health care for people with HIV in Alabama, a technology readiness assessment using a mixed methods approach.
    Eaton EF; Burgan K; McCollum G; Levy S; Willig J; Mugavero MJ; Reddy S; Wallace E; Creger T; Baral S; Fogger S; Cropsey K
    BMC Health Serv Res; 2022 Jul; 22(1):919. PubMed ID: 35841096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk Factors for Overdose in Treatment-Seeking Youth With Substance Use Disorders.
    Yule AM; Carrellas NW; Fitzgerald M; McKowen JW; Nargiso JE; Bergman BG; Kelly JF; Wilens TE
    J Clin Psychiatry; 2018; 79(3):. PubMed ID: 29701935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of COVID-19 lockdown on individuals under treatment for substance use disorders: Risk factors for adverse mental health outcomes.
    Blithikioti C; Nuño L; Paniello B; Gual A; Miquel L
    J Psychiatr Res; 2021 Jul; 139():47-53. PubMed ID: 34029833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.